Melanoma is considered the deadliest skin cancer that can be treated with surgery, radiotherapy, chemotherapy, etc. The use of magnetic iron oxide nanoparticles (IONPs) in order to increase the effectiveness of electron beams and ultrasound beams by increasing the production of free radicals (ROS) and their ability to deliver chemotherapy drugs is under research. Cisplatin is one of the chemotherapy drugs based on platinum, whose ability to deal with melanoma has recently been clarified. In this study, we studied the synthesis of [Formula: see text], [Formula: see text]@L-Aspartic and [Formula: see text]@L-Aspartic@Cisplatin nanoparticles and we managed to determine the characteristics of each of them using TEM, DLS, FTIR, UV–Vis tests; also, MTT and flow cytometry tests were performed for [Formula: see text] and [Formula: see text]@L-Aspartic with the concentrations of 10, 25, 50, 80 and 100 [Formula: see text] g/mL and for [Formula: see text]@L-Aspartic@Cisplatin and cisplatin with concentrations of 0.6, 1.6, 5, 10 and 20 [Formula: see text] g/mL alone and in combination with electron beam with doses of 1 Gy, 2[Formula: see text]Gy and 3[Formula: see text]Gy and ultrasound beam with the intensities of 1[Formula: see text]W/cm2 and 2[Formula: see text]. The results of the mining TEM test show the size of [Formula: see text], [Formula: see text]@L-Aspartic and [Formula: see text]@L-Aspartic@Cisplatin to be 25[Formula: see text]nm, 35[Formula: see text]nm and 42[Formula: see text]nm, and the FTIR and UV–Vis tests also confirmed the nanoparticle coating and drug loading; also, the results of MTT and flow cytometry test showed the effectiveness of [Formula: see text], [Formula: see text]@L-Aspartic and [Formula: see text]@L-Aspartic@Cisplatin in increasing the effectiveness of electron beam and ultrasound beam. The use of nanotechnology together with other treatment methods can shed light on a new way to overcome cancer.
Read full abstract